Sydenham Laboratories

What Sydenham Laboratories does

Sydenham Laboratories, Inc. is a privately held Philippine pharmaceutical manufacturer founded in 1971 by Dr. Eduardo R. dela Cruz, a physician and former president of the Philippine Medical Association. The company produces pharmaceutical and healthcare products across five therapeutic categories — cardiovascular, endocrine, respiratory, anti-infective, and gastrointestinal — and operates from a manufacturing facility in Dasmariñas City, Cavite, employing between 251 and 500 people. The company is named after Dr. Thomas Sydenham, the father of clinical medicine, reflecting its stated orientation around clinical excellence, patient-centered practice, and ethical manufacturing. Specific branded formulations are not publicly listed on the company's website; instead, Sydenham functions primarily as a manufacturing partner to local pharmaceutical companies rather than a consumer-facing brand.

The firm's manufacturing operations are anchored in a GMP-compliant facility featuring HEPA air-handling contamination control and an ISO 9001:2015-certified quality management system held for over two decades. The facility additionally maintains FDA approval from the Philippine Food and Drug Administration, HACCP compliance, and PIC/s readiness — a stack of credentials that positions the company for international pharmaceutical inspection standards. Continuous technological upgrades to the plant are described as the basis for operational efficiency and competitive pricing, but the company has not disclosed proprietary automation, AI/ML capabilities, or differentiated manufacturing technology beyond standard air-handling and quality systems.

Sydenham's business model is a B2B professional services revenue model built on contract and toll manufacturing plus product development services (including regulatory filing support) for local Philippine pharmaceutical company partners. Pricing is negotiated on a project-by-project basis and is not publicly disclosed. Distribution is single-country domestic through direct enterprise engagement, with the company's website serving as the primary marketing and inquiry portal via dedicated forms for Toll/Contract Manufacturing, Product Development, and Career Applications. No external institutional investors, funding rounds, partnerships, acquisitions, or M&A activity are disclosed, indicating a founder-owned, bootstrapped operation that has independently sustained 50+ years of continuous operations.

Name

Sydenham Laboratories

Legal name

Sydenham Laboratories, Inc.

Website

https://sydenhamlab.com

Company type

Private

Founded year

1971

Operating status

Operating

Headcount range

101–250 employees

Short description

Sydenham Laboratories is a Philippine pharmaceutical contract manufacturer founded in 1971, producing cardiovascular, endocrine, respiratory, anti-infective, and gastrointestinal products for local pharmaceutical companies from its GMP-compliant, ISO 9001:2015-certified facility in Dasmariñas City, Cavite.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

akta.pro primary industry

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

Keywords

• Pharmaceutical manufacturing
• Contract manufacturing
• Toll manufacturing
• Product development
• Generic pharmaceuticals

Headquarters

HQ city

Cavite

HQ country

Philippines

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Toll and contract manufacturing services for pharmaceutical products, producing finished dosage forms for local pharmaceutical company partners.
2. Product Development: Research and development services transforming scientific concepts into market-ready therapeutic solutions, including regulatory filing support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Sydenham Laboratories is a Philippine pharmaceutical manufacturer that produces finished dosage forms across cardiovascular, endocrine, respiratory, anti-infective, and gastrointestinal therapeutic areas at its GMP-compliant facility in Dasmariñas City, Cavite. The company offers toll/contract manufacturing services to local pharmaceutical partners and provides product development services that transform scientific concepts into market-ready therapeutic solutions, including regulatory filing support.

Product overview

Sydenham Laboratories is a Philippine pharmaceutical manufacturer that produces a broad portfolio of generic pharmaceutical and healthcare products. The company offers contract and toll manufacturing services as well as product development capabilities. Specific product names are not publicly listed on their website; the products section features a category selector and product image viewer without naming individual formulations or brands. The company positions itself as a partner to local pharmaceutical companies, providing manufacturing and regulatory compliance services rather than operating as a direct-to-consumer brand with named product offerings.

Differentiator

Problem solved

Functional benefit

Products and services

• Toll/Contract Manufacturing Toll and contract manufacturing services that produce finished pharmaceutical dosage forms across cardiovascular, endocrine, respiratory, anti-infective, and gastrointestinal therapeutic areas for local Philippine pharmaceutical company partners at a GMP-compliant, ISO 9001:2015 certified facility with HEPA air-handling.
• Product Development End-to-end pharmaceutical product development that transforms proven scientific concepts into high-quality, market-ready therapeutic solutions, including regulatory filing support, for local pharmaceutical company partners.

Quantifiable outcome

• Quality products manufactured in GMP-compliant facility with ISO certification

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• WuXi AppTec: Asia-based contract development and manufacturing organization with broad pharma services including commercial manufacturing. Relevant as a regional benchmark for CDMO scale and cost-competitive generic manufacturing capability.
• United Laboratories (Unilab): Largest Philippine pharmaceutical manufacturer with a broad generics and OTC portfolio. Operates the same end-market as Sydenham and serves as the dominant local incumbent shaping contract manufacturing demand patterns in the Philippines.
• Teva Pharmaceutical Industries: Global generics leader with extensive finished-dose pharmaceutical manufacturing across multiple therapeutic areas. Therapeutic-area breadth and generic finished-dose focus make Teva a useful reference point for Sydenham's therapeutic portfolio strategy.
• Lonza Group AG: Swiss-headquartered global CDMO providing contract manufacturing across small molecules, biologics, and cell and gene therapies. Comparable as a CDMO of reference for assessing Sydenham's positioning versus the global contract manufacturing competitive set.
• Samsung Biologics: Asia-headquartered large-scale biologics contract manufacturer serving global pharma clients. Relevant as a regional peer illustrating how Asian CDMOs scale internationally; useful as a benchmark for Sydenham's potential expansion trajectory.
• Sun Pharmaceutical Industries: Indian-headquartered global generic pharmaceutical manufacturer with broad finished dosage form capabilities. Comparable in generics-centric manufacturing model and emerging-market cost positioning relevant to Sydenham's regional context.
• Catalent, Inc. Global contract development and manufacturing organization serving pharma and biologics customers worldwide. Represents the upper-bound scale benchmark for CDMO capabilities Sydenham could aspire to partner with or compete against in the SEA region.

Direct peers

• Hizon Laboratories: Philippine pharmaceutical contract manufacturer producing solid-dose generics and supplements. Closely aligned with Sydenham in domestic manufacturing focus, GMP-grade facilities, and toll manufacturing service for local pharmaceutical partners.
• Lloyd Laboratories: Philippine pharmaceutical manufacturer producing generic finished dosage forms for the domestic market. Comparable to Sydenham in scale, geographic scope, and contract manufacturing versus owned-brand business model.
• Pascual Laboratories: Philippine-based pharmaceutical manufacturer producing generic medicines across multiple therapeutic categories. Directly comparable to Sydenham in local manufacturing footprint, therapeutic breadth, and B2B contract manufacturing orientation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/SLI.sydenhamlab

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sydenham Laboratories